Kratom: History, Science and Therapeutic Potential
Editat de Jack E. Henningfield, Chad E. Beyer, Robert B. Raffaen Limba Engleză Paperback – 29 sep 2025
Moreover, kratom and its active alkaloid mitragynine are getting remarkable attention at federal and local governments as more than eight million Americans consume this product annually. Yet, the paucity of information for researchers and clinicians is troublesome.
- Provides healthcare scientists and researchers with awareness on kratom and its emerging trend as a therapy for medical use for many medical applications
- Presents cutting-edge science for healthcare providers of a substance that will soon be as topical as medical marijuana
- Offers scientists and others information to help those involved in emerging decisions regarding legal status and regulations
Preț: 801.14 lei
Preț vechi: 1183.23 lei
-32%
Puncte Express: 1202
Preț estimativ în valută:
141.81€ • 165.44$ • 122.79£
141.81€ • 165.44$ • 122.79£
Carte tipărită la comandă
Livrare economică 19 februarie-05 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780443274121
ISBN-10: 0443274126
Pagini: 262
Dimensiuni: 191 x 235 x 18 mm
Greutate: 0.58 kg
Editura: ELSEVIER SCIENCE
ISBN-10: 0443274126
Pagini: 262
Dimensiuni: 191 x 235 x 18 mm
Greutate: 0.58 kg
Editura: ELSEVIER SCIENCE
Cuprins
Section 1: Background
1. Botany, geographical distribution, and phytochemistry of Mitragyna speciosa (Korth.) and related species
Satya Swathi Nadakuduti, Mengzi Zhang, Larissa C. Laforest and Brian Pearson
2. The scientific evolution of kratom: a historical overview
Thiruventhan Karunakaran, Yathindra Marimuthu, Balasingam Vicknasingam and Marek C. Chawarski
3. Recent patterns and reasons for use
Marc T. Swogger, Kirsten E. Smith, Tianna Torrice and Oliver Grundmann
Section 2: Basic science
4. Chemistry and metabolites: ADME
Manoj Gundeti, Christopher R. Mccurdy and Abhisheak Sharma
Section 3: Current therapeutic uses
5. Kratom-related physical dependence and addiction
Kirsten E. Smith, Darshan Singh and Oliver Grundmann
6. Current therapeutic uses
Norsyifa Harun, Siti Rafidah Yusof and Farah Wahida Suhaimi
Section 4: Pharmaceutical drug development of kratom-derived products
7. Regulation and policy regarding kratom-derived dietary supplements and direct-to-consumer sales
Robert Durkin, Oliver Grundmann and Kirsten E. Smith
8. Patentability and exclusivity of kratom based natural products
Robert Paradiso
Section 5: Concerns
9. Kratom drug–drug (and other) interactions
Robert B. Raffa and Jeanette Mathews
10. Susceptible populations
Robert B. Raffa and Jeanette Mathews
Section 6: Commentaries/Perspectives
11. Kratom purity and quality control issues: an in-depth analysis
Frank Breve
12. Kratom entrepreneurship | exploiting the commercial potential of kratom and its active alkaloids
Chad E. Beyer
13. Equity investment into kratom, mitragynine, and related products
Zachariah Mcintosh-Pearce
14. Medical marijuana as a template for understanding kratom
Soren Shade
1. Botany, geographical distribution, and phytochemistry of Mitragyna speciosa (Korth.) and related species
Satya Swathi Nadakuduti, Mengzi Zhang, Larissa C. Laforest and Brian Pearson
2. The scientific evolution of kratom: a historical overview
Thiruventhan Karunakaran, Yathindra Marimuthu, Balasingam Vicknasingam and Marek C. Chawarski
3. Recent patterns and reasons for use
Marc T. Swogger, Kirsten E. Smith, Tianna Torrice and Oliver Grundmann
Section 2: Basic science
4. Chemistry and metabolites: ADME
Manoj Gundeti, Christopher R. Mccurdy and Abhisheak Sharma
Section 3: Current therapeutic uses
5. Kratom-related physical dependence and addiction
Kirsten E. Smith, Darshan Singh and Oliver Grundmann
6. Current therapeutic uses
Norsyifa Harun, Siti Rafidah Yusof and Farah Wahida Suhaimi
Section 4: Pharmaceutical drug development of kratom-derived products
7. Regulation and policy regarding kratom-derived dietary supplements and direct-to-consumer sales
Robert Durkin, Oliver Grundmann and Kirsten E. Smith
8. Patentability and exclusivity of kratom based natural products
Robert Paradiso
Section 5: Concerns
9. Kratom drug–drug (and other) interactions
Robert B. Raffa and Jeanette Mathews
10. Susceptible populations
Robert B. Raffa and Jeanette Mathews
Section 6: Commentaries/Perspectives
11. Kratom purity and quality control issues: an in-depth analysis
Frank Breve
12. Kratom entrepreneurship | exploiting the commercial potential of kratom and its active alkaloids
Chad E. Beyer
13. Equity investment into kratom, mitragynine, and related products
Zachariah Mcintosh-Pearce
14. Medical marijuana as a template for understanding kratom
Soren Shade